Signs of deferasirox genotoxicity

Cytotechnology

Volumn 66, Issue 4, 2014, Pages 647-654

  Ila, Hasan Basri ^a   Topaktas, Mehmet ^a   Arslan, Mehmet ^a   Büyükleyla, Mehmet ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Deferasirox; Genotoxicity; Iron chelator; Micronucleus test; RAPD test; Reversion test

Indexed keywords

DEFERASIROX; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; GENOTOXICITY; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; LD 50; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; RAT; SALMONELLA TYPHIMURIUM;

RATTUS; SALMONELLA TYPHIMURIUM;

EID: 84904129737     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-013-9617-8     Document Type: Article

References (31)

1. Anderson D, Yardley-Jones A, Vives-Bauza C, Chua-Anusorn W, Cole C, Webb J (2000) Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay. Teratog Carcinog Muagen 20:251-264
2. Beall HD, Liu Y, Siegel D, Bolton EM, Gibson NW, Ross D (1996) Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin. Biochem Pharmacol 51:645-652 (Pubitemid 26079335)
3. Brown KE, Mathahs MM, Broadhurst KA, Weydert J (2006) Chronic iron overload stimulates hepatocyte proliferation and cyclin D1 expression in rodent liver. Transl Res 148:55-62 (Pubitemid 44142352)
4. Chakrabarti SK, Bai C, Subramanian KS (2001) DNA-protein crosslinks induced by nickel compounds in isolated rat lymphocytes: role of reactive oxygen species and specific amino acids. Toxicol Appl Pharmacol 170:153-165 (Pubitemid 32215846)
5. Chantrel-Groussard K, Gaboriau F, Pasdeloup N, Havouis R, Nick H, Pierre JL, Brissot P, Lescoat G (2006) The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox. Eur J Pharmacol 541:129-137 (Pubitemid 43922440)
6. Coogan TP, Rosenblum IY, Barsotti DA (1986) Bleomycin-induced DNA-strand damage in isolated male germ cells. Mutat Res 162:215-218 (Pubitemid 17172502)
7. Dyavaiah M, Rooney JP, Chittur SV, Lin Q, Begley TJ (2011) Autophagy-dependent regulation of the DNA damage response protein ribonucleotide reductase 1. Mol Cancer Res 9:462-475
8. Eknoyan G (2008) Adolphe Quetelet (1796-1874) - the average man and indices of obesity. Nephrol Dial Transplant 23:47-51
9. Elledge SJ, Davis RW (1989) DNA damage induction of ribonucleotide reductase. Mol Cell Biol 9:4932-4940 (Pubitemid 19275963)
10. Elledge SJ, Zhou Z, Allen JB, Navas TA (1993) DNA damage and cell cycle regulation of ribonucleotide reductase. BioEssays 15:333-339
11. Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81-95
12. Ford SJ, Obeidy P, Lovejoy DB, Bedford M, Nichols L, Chadwick C, Tucker O, Lui GY, Kalinowski DS, Jansson PJ, Iqbal TH, Alderson D, Richardson DR, Tselepis C (2013) Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo. Br J Pharmacol 168:1316-1328. doi:10.1111/bph.12045
13. Hakura A, Suzuki S, Sawada S, Sugihara T, Hori Y, Uchida K, Kerns WD, Sagami F, Motooka S, Satoh T (2003) Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors. Regul Toxicol Pharmacol 37:20-27 (Pubitemid 36349334)
14. Juckett MB, Shadley JD, Zheng Y, Klein JP (1998) Desferrioxamine enhances the effects of gamma radiation on clonogenic survival and the formation of chromosomal aberrations in endothelial cells. Radiat Res 149:330-337 (Pubitemid 28150925)
15. Karakaş Z (2009) Talasemi tedavisinde güncel yaklaşimlar ve yeni şelatörler. Turkiye Klinikleri J Pediatr Sci 5:15-27
16. Lui GY, Obeidy P, Ford SJ, Tselepis C, Sharp DM, Jansson PJ, Kalinowski DS, Kovacevic Z, Lovejoy DB, Richardson DR (2013) The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action. Mol Pharmacol 83:179-190. doi:10.1124/mol.112.081893
17. Maron DM, Ames BN (1983) Revised method for the Salmonella mutagenicity test. Mutat Res 113:173-215 (Pubitemid 13120319)
18. Marshall R, Tricta F, Galanello R, Leoni G, Kirkland D, Minto S, Spino M (2003) Chromosomal aberration frequencies in patients with thalassaemia major undergoing therapy with deferiprone and deferoxamine in a comparative crossover study. Mutagenesis 18:457-463 (Pubitemid 37098977)
19. McKnight RE, Gleason AB, Keyes JA, Sahabi S (2006) Binding mode and affinity studies of DNA-binding agents using topoisomerase I DNA unwinding assay. Bioorg Med Chem Lett 17:1013-1017. doi:10.1016/j.bmcl.2006.11.038
20. Noel S, Rath SK (2006) Randomly amplified polymorphic DNA as a tool for genotoxicity: an assessment. Toxicol Ind Health 22:267-275 (Pubitemid 44186625)
21. O'Donnell JP, Gehman M, Keeney JB (2010) Regulators of ribonucleotide reductase inhibit Ty1 mobility in Saccharomyces cerevisiae. Mob DNA 1:23. doi:10.1186/1759-8753-1-23
22. Pires VS, Gaboriau F, Guillon J, Nascimento S, Dassonville A, Lescoat G, Desplat V, Rochette J, Jarry C, Sonnet P (2006) Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes. J Enzyme Inhib Med Chem 21:261-270 (Pubitemid 44083954)
23. Rotfuss A, Schütz P, Bochum S, Volm T, Eberhardt E, Kreirenberg R, Vogel W, Speit G (1986) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60:390-394
24. Schweitzer C, Scaiano JC (2003) Selective binding and local photophysics of the fluorescent cyanine dye PicoGreen in double-stranded and single-stranded DNA. Phys Chem Chem Phys 5:4911-4917
25. Song S, Christova T, Perusini S, Alizadeh S, Bao RY, Miller BW, Hurren R, Jitkova Y, Gronda M, Isaac M, Joseph B, Subramaniam R, Aman A, Chau A, Hogge DE, Weir SJ, Kasper J, Schimmer AD, Al-awar R, Wrana JL, Attisano L (2011) Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers. Cancer Res 71:7628-7639
26. Steegmann-Olmedillas JL (2011) The role of iron in tumour cell proliferation. Clin Transl Oncol 13:71-76
27. Stinson TJ, Jaw S, Jeffery EH, Plewa MJ (1992) The relationship between nickel chloride-induced peroxidation and DNA strand breakage in rat liver. Toxicol Appl Pharmacol 117:98-103
28. Whittaker P, Seifried HE, San HRH, Clarke JJ, Dunkel VC (2001) Genotoxicity of iron chelators in L5178Ymouse lymphoma cells. Environ Mol Mutagen 38:347-356 (Pubitemid 34052171)
29. Witte I, Zhu BZ, Lueken A, Magnani D, Stossberg H, Chevion M (2000) Protection by desferrioxamine and other hydroxamic acids against tetrachlorohydroquinone-induced cyto-and genotoxicity in human fibroblasts. Free Radic Biol Med 28:693-700 (Pubitemid 30171282)
30. Zhang AS, Enns CA (2009) Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem 284:711-715
31. Zhang L, Bandy B, Davison AJ (1996) Effects of metals, ligands and antioxidants on the reaction of oxygen with 1,2,4-benzenetriol. Free Radic Biol Med 20:495-505 (Pubitemid 26097266)